People with myasthenia gravis can develop psychiatric symptoms, including depression and insomnia. However, recommendations regarding safe medication are insufficient. In…
A new extended release formulation of zilucoplan, a potential self-administered therapy for patients with generalized myasthenia gravis (gMG), given once…
Although rare, myasthenia gravis can develop in patients with systemic lupus erythematosus, according to a case study. The study,…
A small regulatory RNA, called microRNA-653, inhibited the proliferation of thymus cells, called thymocytes, in a mouse model of…
Among myasthenia gravis patients (MG), males and those with a higher body mass index are at a higher risk…
Topline results from a Phase 2 trial of  Ra Pharma’s zilucoplan (previously known as RA101495), a potential self-administered therapy for patients with…
The gut microbiome of people with myasthenia gravis is less diverse than that of healthy people, with a rise in…
Use of rituximab can reverse myasthenia gravis-like symptoms in cancer patients being treated with immune checkpoint inhibitors like Opdivo or Yervoy, a…
An interventional program composed of physical activity and psychological support may help improve fatigue levels in myasthenia gravis patients, a…
A small but significant percentage of myasthenia gravis (MG) patients remain resistant to current therapies, which severely impacts on…
Get regular updates to your inbox.
